Reuters notes the “miraculous speed” of mRNA vaccines, while also calling it “a glimpse of what’s possible if it can be applied post-pandemic to treat cancer or rare diseases.” The vaccine market alone is worth about $35 billion each year, and investors apparently believe mRNA companies will capture around two-third of that, leading market researcher Bernstein to evalaute the combined worth…
Tag: rare diseases
Will China Seize an American Company’s Drug For Fighting Coronavirus?
“Chinese researchers reportedly have applied for a local patent on an experimental Gilead drug that they believe could help fight the novel coronavirus outbreak — and also significantly bolster Gilead’s bottom-line going forward…” reports The Street. “If granted, Gilead will need to get Chinese patent owners on board when it wants to sell the drug for treating the novel coronavirus infection…